Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Groen

Showing results (411-420 of 564) with videos related to

Pageof 57
Sort By:
Acta Neurochirurgica|February 8, 2023
The cognitive status of chronic subdural hematoma patients after treatment: an exploratory studyJurre Blaauw, Heleen M den Hertog, Dana C Holl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2011
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III studyB Biesma, A N M Wymenga, A Vincent, et al.
Plos One|January 26, 2013
Variants in the 15q24/25 locus associate with lung function decline in active smokersFirdaus A A Mohamed Hoesein, Els Wauters, Wim Janssens, et al.
Thorax|April 18, 2018
Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON studyJoan E Walter, Marjolein A Heuvelmans, Geertruida H de Bock, et al.
Lung Cancer (Amsterdam, Netherlands)|September 3, 2013
A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancerT Ciuleanu, C-M Tsai, C-J Tsao, et al.
European Journal of Radiology|October 25, 2021
Community-based lung cancer screening by low-dose computed tomography in China: First round results and a meta-analysisYanju Li, Yihui Du, Yubei Huang, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2013
Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trialNanda Horeweg, Carlijn M van der Aalst, Erik Thunnissen, et al.
Cancer Biology & Medicine|May 24, 2019
Methods of computed tomography screening and management of lung cancer in Tianjin: design of a population-based cohort studyYihui Du, Yingru Zhao, Grigory Sidorenkov, et al.
Lung Cancer (Amsterdam, Netherlands)|September 14, 2010
A chronic obstructive pulmonary disease related signature in squamous cell lung cancerMirjam C Boelens, Adam M Gustafson, Dirkje S Postma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Randomized phase III trial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer: AVAPERL (MO22089)Fabrice Barlesi, Arnaud Scherpereel, Achim Rittmeyer, et al.
Pageof 57

Showing results (411-420 of 564) with videos related to

Sort By:
Pageof 57
Acta Neurochirurgica|February 8, 2023
The cognitive status of chronic subdural hematoma patients after treatment: an exploratory studyJurre Blaauw, Heleen M den Hertog, Dana C Holl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2011
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III studyB Biesma, A N M Wymenga, A Vincent, et al.
Plos One|January 26, 2013
Variants in the 15q24/25 locus associate with lung function decline in active smokersFirdaus A A Mohamed Hoesein, Els Wauters, Wim Janssens, et al.
Thorax|April 18, 2018
Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON studyJoan E Walter, Marjolein A Heuvelmans, Geertruida H de Bock, et al.
Lung Cancer (Amsterdam, Netherlands)|September 3, 2013
A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancerT Ciuleanu, C-M Tsai, C-J Tsao, et al.
European Journal of Radiology|October 25, 2021
Community-based lung cancer screening by low-dose computed tomography in China: First round results and a meta-analysisYanju Li, Yihui Du, Yubei Huang, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2013
Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trialNanda Horeweg, Carlijn M van der Aalst, Erik Thunnissen, et al.
Cancer Biology & Medicine|May 24, 2019
Methods of computed tomography screening and management of lung cancer in Tianjin: design of a population-based cohort studyYihui Du, Yingru Zhao, Grigory Sidorenkov, et al.
Lung Cancer (Amsterdam, Netherlands)|September 14, 2010
A chronic obstructive pulmonary disease related signature in squamous cell lung cancerMirjam C Boelens, Adam M Gustafson, Dirkje S Postma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Randomized phase III trial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer: AVAPERL (MO22089)Fabrice Barlesi, Arnaud Scherpereel, Achim Rittmeyer, et al.
Pageof 57